RankAlpha logo
Back to Rankings

CNTX

Context TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Successful CT-202 initiation and constructive CTIM-76 follow-up could re-rate the stock materially from its $0.3763 anchor, while the reported runway allows clinical execution without immediate financing urgency [#PR-EARNINGS-2026-08-05].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Binary efficacy and safety risk across CTIM-76 and CT-202 clinical programs.
Momentum
99
Value
41
Sentiment
76
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.38 · Bull $0.75 · Bear $0.15Analysis 2026-09-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $4.22
Why
Momentum99 · Δ7d -
Value41 · Δ7d -0.0
Sentiment76 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • • Binary efficacy and safety risk across CTIM-76 and CT-202 clinical programs.
  • • Cash runway is management-reported and may be shortened by higher-than-expected clinical or operating costs.
  • • The portfolio is concentrated after CT-95 discontinuation, and the recent ovarian-cancer data reaction highlights binary clinical risk.

Catalyst clock

2026-09-30

CT-202 first patient dosing

Lead driver: Sentiment · See AI snapshot
Momentum
99
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-17.3
Sentiment
76
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 99.1 / Value 41.2 / Sentiment 75.8

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-09. Scenario method

B+
Bull case
20%
Probability
Target price
$0.75
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$0.38
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.15
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$48.72M
Beta
1.91
Shares Out
91.88M
P/E (TTM) · Derived
-1.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.47
Rev YoY
-
EPS YoY
+65.0%
Gross Margin
-
Op Margin
-
Net Debt
-$65.88M
Current Ratio
5.79
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data